Business Trip

What VCs Look for in Psychedelic Companies

Jun 9, 2023

41:57

Highlights

AI Chapters

Episode notes

Effective Evaluation of Psychedelic Care Delivery Companies

01:24

Building a Multi-disciplinary Platform in the Healthcare Industry

01:44

Investment Criteria for Health and Tech-Driven Biology Companies

01:50

Introduction

4min

How to Invest in a Psychedelic Medicine Company

2min

The Future of Psychedelics

2min

Investing in the Psychedelics Space

2min

The Importance of Full Time Teams in the Therapeutic Space

3min

The Importance of Team Dynamics in Venture Capital

2min

Platforms vs. Assets

2min

The Differences Between Private and Public Valuations for Tech Driven Platforms

2min

The Art of Investing in the Therapeutic Space

2min

10.

How to Build a Company at the Early Stages

2min

11.

The Uniqueness of Psychedelics

2min

12.

The Role of IP in Psychedelics

2min

13.

How Jazz Thinks of Psychedelics as an IP Strategy

2min

14.

The Future of Psychedelics

3min

15.

The Future of Care Delivery and Psychedelics

2min

16.

How to Cold Email a Founder

2min

17.

The Role of VCS in Biotech Development

2min

18.

How to Start a Psychic Elixir Company

2min

19.

How to Build a Multi-Disciplinary Neuro Platform

2min

20.

The Future of Psychedelics

2min

21.

Building a Commercial Organization in Frontier Mental Health

3min

What does it take for a traditional VC to fund a psychedelic company? In our latest episode, Matias takes us behind the scenes of a panel discussion at the Psychedelic Therapeutics & Drug Development Conference in San Francisco, CA. Matias talks with VCs at firms with $100M+ fund sizes: Anne Dwane, a partner at Village Global, Amanda Way, principal at Jazz Venture Partners and Dana Watt PhD, principal at Breakout Ventures.

In this episode, we discuss: (1) How VCs identify and evaluate a strong founding team, (2) Evaluating scientific, technical, and market risk, (3) The pros and cons of platforms vs. asset companies, (4) How to position a psychedelic company in the broader biotech ecosystem.

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis, Nico V. Rey & Caitlin Ner
Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Business Trip

What VCs Look for in Psychedelic Companies

Effective Evaluation of Psychedelic Care Delivery Companies

Building a Multi-disciplinary Platform in the Healthcare Industry

Investment Criteria for Health and Tech-Driven Biology Companies

Get the Snipdpodcast app

AI-poweredpodcast player

Discoverhighlights

Save anymoment

Share& Export

AI-poweredpodcast player

Discoverhighlights

Get the Snipd
podcast app

AI-powered
podcast player

Discover
highlights

Save any
moment

Share
& Export

AI-powered
podcast player

Discover
highlights